methamphetamine has been researched along with 3,4-methylenedioxyamphetamine in 114 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (8.77) | 18.7374 |
| 1990's | 29 (25.44) | 18.2507 |
| 2000's | 45 (39.47) | 29.6817 |
| 2010's | 23 (20.18) | 24.3611 |
| 2020's | 7 (6.14) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA | 1 |
| Canfield, DV; Epstein, RL; Lorimer, P | 1 |
| Elayan, I; Foltz, RL; Gibb, JW; Hanson, GR; Johnson, M; Lim, HK | 1 |
| Nash, JF; Yamamoto, BK | 1 |
| Azmitia, EC; Berger, UV; Gu, XF | 1 |
| Glennon, RA; Higgs, R | 1 |
| Farfel, GM; Seiden, LS; Vosmer, GL | 1 |
| Chei, DM; Foltz, RL; Lim, HK; Zeng, S | 1 |
| Gibb, JW; Hanson, GR; Johnson, M; Mitros, K; Stone, DM; Zobrist, R | 1 |
| Katz, JL; Ricaurte, GA; Steele, TD | 1 |
| Bush, LG; Gibb, JW; Hanson, GR; Johnson, M; Midgley, L | 1 |
| Black, CK; Schmidt, CJ; Taylor, VL | 1 |
| Baugh, D; Gan, BK; Liu, RH; Walia, AS | 1 |
| Virus, RM; Woolverton, WL; Zacny, JP | 1 |
| Gibb, JW; Hanson, GR; Johnson, M | 4 |
| Gibb, JW; Hanson, GR; Stahl, DC; Stone, DM | 1 |
| Bush, L; Gibb, JW; Hanson, GR; Johnson, M; Letter, A; Merchant, KM; Sonsalla, P | 1 |
| Brady, JF; Cho, AK; Di Stefano, EW | 1 |
| Fitzgerald, RL; Poklis, A; Ramos, JM | 1 |
| Bush, L; Gibb, JW; Hanson, GR; Letter, AA; Merchant, KM | 1 |
| Frank, RS | 1 |
| Cirimele, V; Kintz, P; Mangin, P; Tracqui, A | 1 |
| Cornish, KG; O'Rourke, MF; Shiue, CY; Shiue, GG | 1 |
| Dasgupta, A; Thompson, WC | 1 |
| Calder, L; Clikeman, J; Finnegan, KT; Karler, R; Wei, S | 1 |
| Castagna, F; Ferrara, SD; Frison, G; Giorgetti, R; Tedeschi, L | 1 |
| Miller, DB; O'Callaghan, JP | 1 |
| Bourquin, D; Bracher, K; Brenneisen, R; Helmlin, HJ; Vonlanthen, D | 1 |
| Barni Comparini, I; Centini, F; Masti, A | 1 |
| Kikura, R; Mieczkowski, T; Nakahara, Y; Tagliaro, F | 1 |
| Brenneisen, R; Lanz, M; Thormann, W | 1 |
| Tretter, F | 1 |
| Gouzoulis-Mayfrank, E; Habermeyer, E; Hermle, L; Kovar, KA; Kunert, HJ; Lindenblatt, H; Sass, H; Spitzer, M; Thelen, B | 1 |
| Arning, C; Büll, U; Gouzoulis-Mayfrank, E; Hermle, L; Kovar, KA; Sabri, O; Sass, H; Schreckenberger, M; Spitzer, M; Thelen, B | 1 |
| Krieg, JC; Mennel, HD; Schäfer, T; Schlegel, J; Stumm, G; Vedder, H; Würz, C | 1 |
| Cody, JT; Hensley, D | 1 |
| Cozzi, NV; Jacob, P; Ruoho, AE; Shulgin, AT; Sievert, MK | 1 |
| Brenneisen, R; Camí, J; de la Torre, R; Farré, M; Mas, M; Ortuño, J; Roset, PN; Segura, J | 1 |
| Dawson, M; Kannangara, GS; Lee, GS; Taylor, RC; Wilson, MA | 1 |
| Fleckenstein, AE; Hanson, GR; Riddle, EL; Sandoval, V; Ugarte, YV | 1 |
| Gudelsky, GA; Vorhees, CV; Wallace, TL | 1 |
| Rome, ES | 1 |
| Brehm, G; Sägmüller, B; Schneider, S; Schwarze, B | 1 |
| Glennon, RA; Young, R | 1 |
| Camí, J; de la Torre, R; Farré, M; Hernández-López, C; Joglar, J; Llebaria, A; Mas, M; Ortuño, J; Pizarro, N; Pujadas, M; Roset, PN; Segura, J | 1 |
| Gouzoulis-Mayfrank, E; Heekeren, K; Kovar, KA; Maier, S; Sass, H; Spitzer, M; Thelen, B | 1 |
| Barnett, DA; Ells, B; Guevremont, R; McCooeye, MA; Mester, Z; Purves, RW | 1 |
| Cano, S; de la Torre, R; Farré, M; Joglar, J; Llebaria, A; Pizarro, N; Segura, J | 1 |
| Cooper, DP; De Boeck, G; De Bruijn, EA; Maes, RA; Morris, M; Samyn, N; Wood, M | 1 |
| Huang, Z; Zhang, S | 1 |
| Horn, CK; Klette, KL; Stout, PR | 1 |
| Katagi, M; Miki, A; Shima, N; Tsuchihashi, H | 1 |
| Kaddoumi, A; Kikura-Hanajiri, R; Nakashima, K | 1 |
| Bassetto, F; Castagna, F; Dall'Olio, G; Marchioro, L; Plebani, M; Tedeschi, L | 1 |
| Becker, KG; Cheadle, C; Donovan, DM; McCann, UD; Mechan, AO; Ricaurte, GA; Tong, L; Xie, T; Yuan, J | 1 |
| de la Torre, R; Farré, M; Joglar, J; Peiró, AM; Pizarro, N; Pujadas, M; Roset, PN | 1 |
| Hugel, J; Kalasinsky, KS; Kish, SJ | 1 |
| Jacobs, A; Jemionek, J; Lesser, D; Paul, BD; Searles, DA | 1 |
| Jeng, W; Parman, T; Ramkissoon, A; Wells, PG | 1 |
| Johansen, SS; Olsen, KH; Rasmussen, LB | 1 |
| Abraham, TT; Huestis, MA; Pirnay, SO | 1 |
| Crean, RD; Davis, SA; Katner, SN; Lay, CC; Taffe, MA; Von Huben, SN | 1 |
| Ehrman, LA; Gudelsky, GA; Schaefer, TL; Vorhees, CV; Williams, MT | 1 |
| Abraham, TT; Huestis, MA; Lowe, RH; Pirnay, SO | 1 |
| Cody, JT; Phelix, CF; Valtier, S | 1 |
| Goda, Y; Kawamura, M; Kikura-Hanajiri, R; Kodama, Y; Saisho, K | 1 |
| Kamata, H; Katagi, M; Nemoto, N; Sakuma, T; Shima, N; Tsuchihashi, H | 1 |
| Maurer, HH; Mueller, M; Peters, FT; Ricaurte, GA | 2 |
| Andersson, M; Beck, O; Gustavsson, E; Stephanson, N | 1 |
| Huestis, MA; Kolbrich, EA; Lowe, RH | 1 |
| Kamata, H; Kamata, T; Katagi, M; Miki, A; Nemoto, N; Nishikawa, M; Sakuma, T; Shima, N; Tsuchihashi, H; Zaitsu, K | 1 |
| Ishii, H; Nakagawa, Y; Ogata, A; Suzuki, T; Tayama, S | 1 |
| Cheong, JC; In, MK; Kim, JY; Kim, MK; Lee, JI | 1 |
| Aasim, WR; Gan, SH; Tan, SC | 1 |
| Sun, J; Wang, C; Xu, X; You, T | 1 |
| Braitberg, G; Greene, SL; Kerr, F | 1 |
| Bafile, E; Compagnone, D; Curini, R; D'Ascenzo, G; Romolo, FS; Sergi, M | 1 |
| Cheong, JC; In, MK; Jin, C; Kim, JY; Ko, BJ; Lee, SK; Yoo, HH | 1 |
| Huestis, MA; Maurer, HH; Mueller, M; Peters, FT; Ricaurte, GA | 1 |
| Fukuhara, K; Goda, Y; Okuda, H; Shoda, T | 1 |
| Abraham, TT; Barnes, AJ; Goodwin, RS; Gorelick, DA; Huestis, MA; Kolbrich Spargo, EA; Lowe, RH; Milman, G; Pirnay, SO | 1 |
| Hart, CL; Krauss, RM; Marrone, GF; Pardo, JS | 1 |
| In, MK; Kim, JY; Lee, JI; Shin, SH | 1 |
| Bastos, ML; Branco, P; Carmo, H; Carvalho, F; da Silva, DG; de Pinho, PG; Ferreira, L; Pontes, H; Remião, F | 1 |
| Maurer, HH; Meyer, MR; Peters, FT; Wilhelm, J | 1 |
| Ramkissoon, A; Wells, PG | 1 |
| Blacik, LJ; Kazarian, CM; Ntamack, AG; Romberg, RW; Snyder, JJ; Welsh, ER | 1 |
| Inoue, H; Miyaguchi, H | 1 |
| Chen, BH; Chen, PH; Lee, HH; Lee, JF; Lin, SY | 1 |
| Hondebrink, L; Meulenbelt, J; van den Berg, M; van Kleef, RG; Westerink, RH | 1 |
| Baylor, MR; Bynum, ND; Lewallen, CM; Mitchell, JM; Ropero-Miller, JD; Stout, PR | 1 |
| Hondebrink, L; Meijer, M; Meulenbelt, J; Rietjens, SJ; Westerink, RH | 1 |
| Aaron, C; Freeman, S; Hedge, M; Leonard, K; Warrick, BJ; Wilson, J | 1 |
| Baker, DR; Kasprzyk-Hordern, B | 1 |
| Camarasa, J; Escubedo, E; López-Arnau, R; Martínez-Clemente, J; Pubill, D | 1 |
| Baumann, MH; Concheiro, M; Huestis, MA; Marrone, GF; Rothman, RB; Scheidweiler, KB | 1 |
| Baumann, MH; Blough, BE; Goldberg, SR; Schindler, CW; Tella, SR; Thorndike, EB | 1 |
| Covaci, A; Erratico, C; Kinyua, J; Lai, FY; Mueller, JF; van Nuijs, AL | 1 |
| Kraemer, T; Liechti, ME; Rickli, A; Schmid, Y; Schmidhauser, C; Steuer, AE | 1 |
| Górska, A; Gołembiowska, K; Jurczak, A; Kamińska, K; Noworyta-Sokołowska, K | 1 |
| Bagnall, J; Evans, SE; Kasprzyk-Hordern, B | 1 |
| Baumann, MH; Bukhari, MO; Holy, M; Lehner, KR; Li, Y; Partilla, JS; Saha, K; Sandtner, W; Sitte, HH | 1 |
| Burgueño, MJ; Castro, MÁ; Mateos-Campos, R; Sánchez, S | 1 |
| Cui, J; Liu, W; Shen, B; Shen, M; Wang, X; Xiang, P; Zhang, S; Zhuo, Y | 1 |
| Hudson, M; McDonnell, JM; Pollard, C; Royall, PG; Wolff, K | 1 |
| Ducret, P; Hoener, MC; Kolaczynska, KE; Liechti, ME; Luethi, D; Trachsel, D | 1 |
| Coulter, C; Garnier, M; Moore, C | 1 |
| Cruz, SL; Paz-Ramos, MI; Violante-Soria, V | 1 |
| Cui, SF; Huang, X; Wan, JW; Yang, HL | 1 |
| Beradinelli, D; Berretta, P; Busardò, FP; Chankvetadze, B; Di Giorgi, A; Farkas, T; Farre, M; Lo Faro, AF; Papaseit, E; Poyatos, L; Sprega, G; Takaishvili, N; Tini, A | 1 |
3 review(s) available for methamphetamine and 3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
It's a rave new world: rave culture and illicit drug use in the young.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Ephedrine; Flunitrazepam; Humans; Illicit Drugs; Ketamine; Methamphetamine; Sodium Oxybate; Substance-Related Disorders | 2001 |
Review article: amphetamines and related drugs of abuse.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine-Related Disorders; Amphetamines; Benzodiazepines; Charcoal; Drug Overdose; Humans; Methamphetamine | 2008 |
Amphetamine-type Stimulants: Novel Insights into their Actions and use Patterns.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Central Nervous System Stimulants; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 2023 |
8 trial(s) available for methamphetamine and 3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adolescent; Adult; Chromatography, High Pressure Liquid; Deoxyepinephrine; Female; Fluorocarbons; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Hydrolysis; Ion Exchange Resins; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reference Standards | 1996 |
Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.
Topics: 3,4-Methylenedioxyamphetamine; Acute-Phase Reaction; Adult; Aged; Autonomic Agents; Central Nervous System Stimulants; Double-Blind Method; Female; Hallucinogens; Humans; Male; Methamphetamine; Middle Aged; Neurosecretory Systems; Psilocybin; Psychopathology | 1999 |
Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Agents; Adult; Cerebellum; Cognition; Double-Blind Method; Female; Glucose; Hallucinogens; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Nootropic Agents; Psilocybin; Psychopathology; Radionuclide Imaging | 1999 |
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Area Under Curve; Blood Pressure; Cross-Over Studies; Deoxyepinephrine; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Hallucinogens; Humans; Hydrogen-Ion Concentration; Male; Metabolic Clearance Rate; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Pilot Projects; Time Factors | 2000 |
Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
Topics: 3,4-Methylenedioxyamphetamine; Deoxyepinephrine; Electrophoresis, Capillary; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Substance Abuse Detection | 2002 |
Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Attention; Central Nervous System Stimulants; Double-Blind Method; Female; Hallucinogens; Humans; Male; Methamphetamine; Middle Aged; Psilocybin; Reaction Time; Space Perception; Visual Perception | 2002 |
Amphetamine analogs methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially affect speech.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Affect; Arousal; Attention; Central Nervous System Stimulants; Double-Blind Method; Female; Humans; Male; Methamphetamine; Self Concept; Speech; Speech Intelligibility; Young Adult | 2010 |
Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans.
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Methamphetamine; Stereoisomerism; Young Adult | 2015 |
103 other study(ies) available for methamphetamine and 3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |
Gas chromatographic analysis of amphetamine derivatives and morpholine-related drugs.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Benzphetamine; Chromatography, Gas; DOM 2,5-Dimethoxy-4-Methylamphetamine; Ephedrine; Forensic Medicine; Mescaline; Methamphetamine; Morpholines; Phentermine; Phenylpropanolamine | 1977 |
Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Chromatography, High Pressure Liquid; Dopamine; Injections, Intraventricular; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Serotonin; Tryptophan Hydroxylase | 1992 |
Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Analysis of Variance; Animals; Aspartic Acid; Corpus Striatum; Designer Drugs; Dialysis; Dopamine; Glutamates; Kinetics; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; Rats; Rats, Wistar; Reference Values; Taurine; Time Factors | 1992 |
The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Calcium; Cocaine; Fenfluramine; Fluoxetine; In Vitro Techniques; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; p-Chloroamphetamine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Synaptosomes | 1992 |
Investigation of MDMA-related agents in rats trained to discriminate MDMA from saline.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Discrimination, Psychological; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley | 1992 |
The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dizocilpine Maleate; Hippocampus; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; N-Methylaspartate; p-Chloroamphetamine; Rats; Serotonin | 1992 |
Comparative investigation of disposition of 3,4-(methylenedioxy)methamphetamine (MDMA) in the rat and the mouse by a capillary gas chromatography-mass spectrometry assay based on perfluorotributylamine-enhanced ammonia positive ion chemical ionization.
Topics: 3,4-Methylenedioxyamphetamine; Ammonia; Animals; Dopamine; Fluorocarbons; Gas Chromatography-Mass Spectrometry; Male; Methamphetamine; Mice; Mice, Inbred Strains; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Species Specificity | 1992 |
Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Chromatography, High Pressure Liquid; Diltiazem; Drug Interactions; Enzyme Induction; Flunarizine; Hydroxyindoleacetic Acid; Injections, Subcutaneous; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nimodipine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Serotonin; Tryptophan Hydroxylase | 1992 |
Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain Chemistry; Hallucinogens; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Rats; Rats, Sprague-Dawley; Serotonin; Structure-Activity Relationship | 1992 |
MK-801 blocks the changes in neurotensin concentrations induced by methamphetamine, 3,4-methylenedioxymethamphetamine, cocaine, and GBR 12909.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Cocaine; Dizocilpine Maleate; Male; Methamphetamine; Neurotensin; Piperazines; Rats; Rats, Sprague-Dawley | 1992 |
L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Dopamine; Drug Synergism; Fenfluramine; Hippocampus; Levodopa; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Nerve Endings; Nervous System Diseases; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Serotonin | 1991 |
Simultaneous analysis of amphetamine, methamphetamine, and 3, 4-methylenedioxymethamphetamine (MDMA) in urine samples by solid-phase extraction, derivatization, and gas chromatography/mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Calibration; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; Predictive Value of Tests; Reproducibility of Results | 1991 |
Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Dose-Response Relationship, Drug; Drinking Behavior; Drug Tolerance; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains | 1990 |
Neurochemical basis of neurotoxicity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biogenic Monoamines; Designer Drugs; Dopamine; Glutamates; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System; Nervous System Diseases; Serotonin | 1990 |
The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain; Hydroxyindoleacetic Acid; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Serotonin; Tryptophan Hydroxylase | 1987 |
Effects of amphetamine analogs on central nervous system neuropeptide systems.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain Chemistry; Dynorphins; Extrapyramidal Tracts; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neuropeptides; Neurotensin; Rats; Rats, Inbred Strains; Substance P | 1989 |
Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Anticonvulsants; Dibenzocycloheptenes; Dizocilpine Maleate; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Tryptophan Hydroxylase | 1989 |
MK-801 attenuates the methamphetamine induced decreased in tryptophan hydroxylase activity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Anticonvulsants; Brain; Corpus Striatum; Dibenzocycloheptenes; Dizocilpine Maleate; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Rats; Rats, Inbred Strains; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Receptors, Serotonin; Tryptophan Hydroxylase | 1989 |
Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphetamine (MDA) and (+/-)-3,4-methylenedioxymethamphetamine (MDMA) with rat hepatic microsomes.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Benzphetamine; Cytochrome P-450 Enzyme System; Kinetics; Male; Methamphetamine; Methimazole; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; NADP; Oxidoreductases, N-Demethylating; Rats; Spectrophotometry | 1986 |
MDMA and MDA cross reactivity observed with Abbott TDx amphetamine/methamphetamine reagents.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamine; Amphetamines; Cross Reactions; Female; Fluorescence Polarization; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reagent Kits, Diagnostic | 1988 |
Characterization of methamphetamine effects on the striatal-nigral dynorphin system.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dynorphins; Hydroxydopamines; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Oxidopamine; Radioimmunoassay; Rats; Rats, Inbred Strains; Substantia Nigra; Sympathectomy, Chemical | 1988 |
Effects of dopaminergic and serotonergic receptor blockade on neurochemical changes induced by acute administration of methamphetamine and 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Haloperidol; Male; Methamphetamine; Methiothepin; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Ritanserin; Serotonin Antagonists | 1988 |
The clandestine drug laboratory situation in the United States.
Topics: 3,4-Methylenedioxyamphetamine; Acetone; Amphetamine; Drug and Narcotic Control; Humans; Illicit Drugs; Methamphetamine; Methaqualone; Pharmaceutical Preparations; Phencyclidine; Substance-Related Disorders; United States | 1983 |
Simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in human hair by gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance-Related Disorders | 1995 |
Comparative PET studies of the distribution of (-)-3,4-methylenedioxy-N-[11C]methamphetamine and (-)-[11C]methamphetamine in a monkey brain.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Carbon Radioisotopes; Half-Life; Injections, Intravenous; Macaca mulatta; Male; Methamphetamine; Tomography, Emission-Computed | 1995 |
Microwave-induced rapid preparation of fluoro-derivatives of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine for GC-MS confirmation assays.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Calibration; Designer Drugs; Fluorides; Gas Chromatography-Mass Spectrometry; Methamphetamine; Microwaves; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine | 1994 |
Effects of L-type calcium channel antagonists on the serotonin-depleting actions of MDMA in rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Calcium Channel Blockers; Cerebral Cortex; Flunarizine; Haloperidol; Hippocampus; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nifedipine; Rats; Rats, Sprague-Dawley; Seizures; Serotonin; Stereotyped Behavior; Verapamil | 1993 |
Simultaneous identification of amphetamine and its derivatives in urine using HPLC-UV.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Treatment Centers; Substance-Related Disorders; Ultraviolet Rays | 1993 |
The interactions of MK-801 with the amphetamine analogues D-methamphetamine (D-METH), 3,4-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): neural damage and neural protection.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biomarkers; Brain; Cerebral Cortex; Corpus Striatum; Dizocilpine Maleate; Female; Fenfluramine; Glial Fibrillary Acidic Protein; Hippocampus; Methamphetamine; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neurotoxins | 1993 |
Quantitative and qualitative analysis of MDMA, MDEA, MA and amphetamine in urine by headspace/solid phase micro-extraction (SPME) and GC/MS.
Topics: 3,4-Methylenedioxyamphetamine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 1996 |
Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Lactates; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Substance Abuse Detection; Substance-Related Disorders | 1997 |
Enantioselective determination of 3,4-methylene-dioxymethamphetamine and two of its metabolites in human urine by cyclodextrin-modified capillary zone electrophoresis.
Topics: 3,4-Methylenedioxyamphetamine; Cyclodextrins; Dopamine; Electrophoresis, Capillary; Humans; Methamphetamine; Molecular Conformation; N-Methyl-3,4-methylenedioxyamphetamine | 1997 |
[Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychoses, Substance-Induced; Risk Factors | 1997 |
Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons.
Topics: 3,4-Methylenedioxyamphetamine; Alternative Splicing; Amphetamines; Animals; Apoptosis; bcl-X Protein; Dextroamphetamine; DNA Fragmentation; Gene Expression Regulation; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neocortex; Neurons; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar | 1999 |
Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Central Nervous System Stimulants; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity; Stereoisomerism; Substance Abuse Detection; Time Factors; Urine | 1999 |
Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Cattle; Cell Membrane; Chromaffin Cells; Dopamine; Dopamine Uptake Inhibitors; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Neuropeptides; Norepinephrine; Propiophenones; Serotonin; Tritium; Tumor Cells, Cultured; Vesicular Biogenic Amine Transport Proteins | 1999 |
High-resolution solid state 13C nuclear magnetic resonance spectra of 3,4-methylenedioxyamphetamine hydrochloride and related compounds and their mixtures with lactose.
Topics: 3,4-Methylenedioxyamphetamine; Carbon Isotopes; Crystallization; Ephedrine; Hydrogen Bonding; Lactose; Magnetic Resonance Spectroscopy; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Solutions; Stereoisomerism | 2000 |
Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biological Transport; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Male; Membrane Glycoproteins; Membrane Potentials; Membrane Transport Proteins; Methamphetamine; Methylphenidate; Models, Biological; Nerve Tissue Proteins; Norepinephrine; Onium Compounds; Organophosphorus Compounds; Phosphorylation; Protein Kinase C; Rats; Rats, Sprague-Dawley; Serotonin; Synaptosomes | 2001 |
Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biogenic Monoamines; Circadian Rhythm; Dopamine Agents; Male; Methamphetamine; Motor Activity; Rats; Rats, Sprague-Dawley | 2001 |
Application of SERS spectroscopy to the identification of (3,4-methylenedioxy)amphetamine in forensic samples utilizing matrix stabilized silver halides.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Spectrum Analysis, Raman | 2001 |
Effect of 1-(3,4-methylenedioxyphenyl)-2-aminopropane and its optical isomers in PMMA-trained rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Discrimination Learning; Dose-Response Relationship, Drug; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Stereoisomerism | 2002 |
Quantitation of amphetamine, methamphetamine, and their methylenedioxy derivatives in urine by solid-phase microextraction coupled with electrospray ionization-high-field asymmetric waveform ion mobility spectrometry-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Central Nervous System Stimulants; Hallucinogens; Humans; Indicators and Reagents; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection | 2002 |
Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Male; Methamphetamine; Molecular Conformation; Reference Values; Reproducibility of Results; Substance Abuse Detection | 2003 |
Development of a rapid and sensitive method for the quantitation of amphetamines in human plasma and oral fluid by LC-MS-MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Chromatography, Liquid; Ephedrine; Humans; Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Saliva; Substance Abuse Detection | 2003 |
Confirmation of amphetamine, methamphetamine, MDA and MDMA in urine samples using disk solid-phase extraction and gas chromatography-mass spectrometry after immunoassay screening.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Gas Chromatography-Mass Spectrometry; Immunoassay; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine | 2003 |
Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Central Nervous System Stimulants; Ephedrine; False Positive Reactions; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Immunoassay; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Online Systems; Phenylpropanolamine; Reagent Kits, Diagnostic; Substance Abuse Detection; Sympathomimetics | 2004 |
Application of ORAL.screen saliva drug test for the screening of methamphetamine, MDMA, and MDEA incorporated in hair.
Topics: 3,4-Methylenedioxyamphetamine; Forensic Medicine; Hair; Humans; Immunoassay; Immunochemistry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reagent Kits, Diagnostic; Saliva; Substance Abuse Detection | 2004 |
High-performance liquid chromatography with fluorescence detection for the simultaneous determination of 3,4-methylenedioxymethamphetamine, methamphetamine and their metabolites in human hair using DIB-Cl as a label.
Topics: 3,4-Methylenedioxyamphetamine; Chromatography, High Pressure Liquid; Hair; Humans; Methamphetamine; Spectrometry, Fluorescence; Substance Abuse Detection | 2004 |
Amphetamines and 3,4-methylendioxymetamphetamine (MDMA): evaluation of KIMS (kinetic interaction of microparticles in solution) assay at two cut-off levels.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamines; Chromatography, High Pressure Liquid; Clinical Chemistry Tests; Enzyme Multiplied Immunoassay Technique; Female; Gas Chromatography-Mass Spectrometry; Humans; Immunoassay; Male; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Nanostructures; Predictive Value of Tests; Sensitivity and Specificity; Substance-Related Disorders | 2004 |
Identification and characterization of metallothionein-1 and -2 gene expression in the context of (+/-)3,4-methylenedioxymethamphetamine-induced toxicity to brain dopaminergic neurons.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Blotting, Northern; Brain; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Illicit Drugs; Male; Metallothionein; Methamphetamine; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Time Factors | 2004 |
Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
Topics: 3,4-Methylenedioxyamphetamine; Administration, Oral; Area Under Curve; Catechol O-Methyltransferase; Cytochrome P-450 CYP2D6; Deoxyepinephrine; Half-Life; Humans; Male; Methamphetamine; Methods; Phenotype; Polymorphism, Genetic; Stereoisomerism | 2004 |
Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamine; Canada; Cocaine; Dopamine Uptake Inhibitors; Drug Contamination; Female; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Illicit Drugs; Male; Methamphetamine; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine | 2004 |
Enantiomeric separation and quantitation of (+/-)-amphetamine, (+/-)-methamphetamine, (+/-)-MDA, (+/-)-MDMA, and (+/-)-MDEA in urine specimens by GC-EI-MS after derivatization with (R)-(-)- or (S)-(+)-alpha-methoxy-alpha-(trifluoromethy)phenylacetyl chlor
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Chromatography, Gas; Chromatography, Ion Exchange; Humans; Indicators and Reagents; Methamphetamine; Military Personnel; N-Methyl-3,4-methylenedioxyamphetamine; Quaternary Ammonium Compounds; Reference Standards; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Substance Abuse Detection | 2004 |
Prostaglandin H synthase-catalyzed bioactivation of amphetamines to free radical intermediates that cause CNS regional DNA oxidation and nerve terminal degeneration.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Uptake Inhibitors; Amphetamines; Animals; Aspirin; Brain; Cyclooxygenase Inhibitors; DNA; Dose-Response Relationship, Drug; Female; Free Radicals; Methamphetamine; Mice; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Oxidation-Reduction; Prostaglandin-Endoperoxide Synthases; Psychomotor Performance; Synapses | 2006 |
Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Gas; Humans; Methamphetamine; Molecular Structure; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Substance Abuse Detection | 2006 |
Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Calibration; Central Nervous System Stimulants; Dopamine; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Sensitivity and Specificity; Substance Abuse Detection | 2006 |
Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Body Temperature; Dose-Response Relationship, Drug; Hallucinogens; Macaca mulatta; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Time Factors | 2006 |
Comparison of monoamine and corticosterone levels 24 h following (+)methamphetamine, (+/-)3,4-methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat.
Topics: 3,4-Methylenedioxyamphetamine; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Biogenic Monoamines; Body Weight; Brain Chemistry; Chromatography, High Pressure Liquid; Cocaine; Corpus Striatum; Corticosterone; Electrochemistry; Female; Fenfluramine; Hippocampus; Immunoenzyme Techniques; Male; Maze Learning; Methamphetamine; Methylphenidate; Neurotransmitter Uptake Inhibitors; Pregnancy; Rats; Rats, Sprague-Dawley | 2006 |
Selection and optimization of hydrolysis conditions for the quantification of urinary metabolites of MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Dopamine; Forensic Toxicology; Glucuronidase; Hallucinogens; Humans; Hydrochloric Acid; Hydrolysis; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2006 |
Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biotransformation; Calibration; Dopamine; Gas Chromatography-Mass Spectrometry; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Psychotropic Drugs; Rats; Reproducibility of Results; Toxicology | 2007 |
The disposition into hair of new designer drugs; methylone, MBDB and methcathinone.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Gas Chromatography-Mass Spectrometry; Hair; Methamphetamine; Models, Animal; Propiophenones; Rats | 2007 |
Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine-Related Disorders; Calibration; Designer Drugs; Gas Chromatography-Mass Spectrometry; Glucuronides; Hallucinogens; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Substance Abuse Detection; Sulfates | 2007 |
Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxym
Topics: 3,4-Methylenedioxyamphetamine; Animals; Calibration; Chromatography, Liquid; Deoxyepinephrine; Hallucinogens; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Saimiri; Spectrometry, Mass, Electrospray Ionization | 2007 |
Direct injection LC-MS/MS method for identification and quantification of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in urine drug testing.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, Liquid; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance Abuse Detection; Tandem Mass Spectrometry | 2008 |
Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma.
Topics: 3,4-Methylenedioxyamphetamine; Calibration; Central Nervous System Stimulants; Dopamine; Gas Chromatography-Mass Spectrometry; Humans; Hydrolysis; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance Abuse Detection | 2008 |
Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Glucuronides; Humans; Male; Mass Spectrometry; Methamphetamine; Rats; Rats, Wistar; Sulfates | 2008 |
Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes.
Topics: 3,4-Methylenedioxyamphetamine; Adenosine Triphosphate; Animals; Cell Death; DNA Damage; Hallucinogens; Hepatocytes; Male; Methamphetamine; Mitochondria, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Oxidative Phosphorylation; Rats; Rats, Inbred F344; Time Factors | 2009 |
Simultaneous determination of amphetamine-type stimulants and cannabinoids in fingernails by gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamine-Related Disorders; Amphetamines; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Marijuana Abuse; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nails; Observer Variation; Reproducibility of Results; Substance Abuse Detection | 2008 |
Development of a simultaneous liquid-liquid extraction and chiral derivatization method for stereospecific GC-MS analysis of amphetamine-type stimulants in human urine using fractional factorial design.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Gas Chromatography-Mass Spectrometry; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Substance Abuse Detection | 2008 |
Liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethampheta
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Brain Chemistry; Chromatography, Liquid; Deoxyepinephrine; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2008 |
Analysis of amphetamines in urine with liquid-liquid extraction by capillary electrophoresis with simultaneous electrochemical and electrochemiluminescence detection.
Topics: 2,2'-Dipyridyl; 3,4-Methylenedioxyamphetamine; Amphetamines; Electrochemical Techniques; Electrophoresis, Capillary; Female; Humans; Luminescent Measurements; Methamphetamine; Microelectrodes; N-Methyl-3,4-methylenedioxyamphetamine; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Multiclass analysis of illicit drugs in plasma and oral fluids by LC-MS/MS.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Body Fluids; Calibration; Chromatography, High Pressure Liquid; Cocaine; Dronabinol; Humans; Illicit Drugs; Ketamine; Methamphetamine; Morphine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Sensitivity and Specificity; Tandem Mass Spectrometry; Time Factors | 2009 |
Simultaneous determination of methamphetamine, 3,4-methylenedioxy-N-methylamphetamine, 3,4-methylenedioxy-N-ethylamphetamine, N,N-dimethylamphetamine, and their metabolites in urine by liquid chromatography-electrospray ionization-tandem mass spectrometry
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Indicators and Reagents; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2008 |
Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxya
Topics: 3,4-Methylenedioxyamphetamine; Animals; Chromatography, Liquid; Deoxyepinephrine; Forensic Toxicology; Hallucinogens; Humans; Hydrolysis; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Saimiri; Spectrometry, Mass, Electrospray Ionization | 2009 |
4-Hydroxy-3-methoxymethamphetamine glucuronide as a phase II metabolite of 3,4-methylenedioxymethamphetamine: enzyme-assisted synthesis and involvement of human hepatic uridine 5'-diphosphate-glucuronosyltransferase 2B15 in the glucuronidation.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Chromatography, High Pressure Liquid; Glucuronates; Glucuronides; Glucuronosyltransferase; Humans; Methamphetamine; Microsomes, Liver; Molecular Structure; Rats | 2009 |
Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Female; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection; Young Adult | 2009 |
Rapid and simple determination of psychotropic phenylalkylamine derivatives in human hair by gas chromatography-mass spectrometry using micro-pulverized extraction.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Hair; Hallucinogens; Humans; Ketamine; Limit of Detection; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Substance Abuse Detection | 2010 |
Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Dopamine; Gas Chromatography-Mass Spectrometry; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Sensitivity and Specificity | 2010 |
Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Designer Drugs; Gas Chromatography-Mass Spectrometry; Humans; Male; Methamphetamine; Rats; Rats, Wistar | 2010 |
Human prostaglandin H synthase (hPHS)-1 and hPHS-2 in amphetamine analog bioactivation, DNA oxidation, and cytotoxicity.
Topics: 3,4-Methylenedioxyamphetamine; 8-Hydroxy-2'-Deoxyguanosine; Animals; Aspirin; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Cyclooxygenase 1; Cyclooxygenase 2; Deoxyguanosine; DNA; Enzyme Activation; Humans; Methamphetamine; Oxidation-Reduction; Transfection | 2011 |
Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Deuterium; Gas Chromatography-Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Solid Phase Extraction; Substance Abuse Detection | 2011 |
Determination of amphetamine-type stimulants, cocaine and ketamine in human hair by liquid chromatography/linear ion trap-Orbitrap hybrid mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Chromatography, Liquid; Cocaine; Hair; Humans; Illicit Drugs; Ketamine; Limit of Detection; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Tandem Mass Spectrometry | 2011 |
Simultaneous determination of HFBA-derivatized amphetamines and ketamines in urine by gas chromatography-mass spectrometry.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Fluorocarbons; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Ketamine; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Solid Phase Extraction; Substance Abuse Detection | 2011 |
Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Binding, Competitive; Dose-Response Relationship, Drug; GABA Modulators; gamma-Aminobutyric Acid; Humans; Illicit Drugs; Membrane Potentials; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Oocytes; Patch-Clamp Techniques; Piperazines; Receptors, GABA-A; Time Factors; Xenopus laevis | 2011 |
A comparison of the validity of gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry analysis of urine samples II: amphetamine, methamphetamine, (±)-3,4-methylenedioxyamphetamine, (±)-3,4-methylenedioxymethamphetamine, (
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Chromatography, High Pressure Liquid; Dronabinol; Gas Chromatography-Mass Spectrometry; Illicit Drugs; Methamphetamine; Phencyclidine; Reproducibility of Results; Substance Abuse Detection; Tandem Mass Spectrometry | 2010 |
Methamphetamine, amphetamine, MDMA ('ecstasy'), MDA and mCPP modulate electrical and cholinergic input in PC12 cells.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Agents; Amphetamine; Animals; Calcium; Cholinergic Agents; Dose-Response Relationship, Drug; Membrane Potentials; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; PC12 Cells; Piperazines; Potassium Chloride; Rats; Serotonin Receptor Agonists | 2012 |
Lethal serotonin syndrome after methylone and butylone ingestion.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Fatal Outcome; Female; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin Syndrome; Young Adult | 2012 |
Estimation of community-wide drugs use via stereoselective profiling of sewage.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; England; Humans; Illicit Drugs; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Prescription Drugs; Sewage; Stereoisomerism; Substance Abuse Detection; Substance-Related Disorders | 2012 |
Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Carrier Proteins; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Ketanserin; Male; Methamphetamine; Mice; Molecular Structure; Motor Activity; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Synaptosomes | 2012 |
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Area Under Curve; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin | 2014 |
Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiovascular System; Consciousness; Deoxyepinephrine; Dopamine; Dose-Response Relationship, Drug; Hallucinogens; Heart Rate; Male; Metabolic Detoxication, Phase I; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Telemetry; Time Factors | 2014 |
Liquid chromatography-quadrupole time-of-flight mass spectrometry for screening in vitro drug metabolites in humans: investigation on seven phenethylamine-based designer drugs.
Topics: 3,4-Methylenedioxyamphetamine; Amines; Amphetamines; Benzodioxoles; Benzofurans; Butylamines; Catalysis; Chromatography, Liquid; Cytochrome P-450 Enzyme System; Cytosol; Designer Drugs; Dose-Response Relationship, Drug; Female; Humans; Likelihood Functions; Liver; Male; Mass Spectrometry; Methamphetamine; Microsomes, Liver; Models, Chemical; Phenethylamines; Propylamines; Reproducibility of Results; Substance Abuse Detection; Wastewater; Water Purification | 2015 |
Effect of Some Psychoactive Drugs Used as 'Legal Highs' on Brain Neurotransmitters.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain; Corpus Striatum; Dopamine; Frontal Lobe; Methamphetamine; Psychotropic Drugs; Rats; Serotonin | 2016 |
Enantioselective degradation of amphetamine-like environmental micropollutants (amphetamine, methamphetamine, MDMA and MDA) in urban water.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Biodegradation, Environmental; Kinetics; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Photochemical Processes; Rivers; Sewage; Stereoisomerism; Wastewater; Water; Water Microbiology | 2016 |
The synthetic cathinones, butylone and pentylone, are stimulants that act as dopamine transporter blockers but 5-HT transporter substrates.
Topics: 3,4-Methylenedioxyamphetamine; Alkaloids; Amphetamines; Animals; Central Nervous System Stimulants; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Male; Methamphetamine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Synaptosomes; Synthetic Drugs | 2019 |
[High-risk drug use: epidemiological pattern through hair testing in the forensic context].
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamine; Cannabinoids; Cocaine; Cross-Sectional Studies; Female; Forensic Sciences; Gas Chromatography-Mass Spectrometry; Hair; Heroin; Humans; Illicit Drugs; Ketamine; Male; Methadone; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Spain; Substance Abuse Detection; Substance-Related Disorders; Young Adult | 2019 |
A Retrospective of Prevalence of Drugs of Abuse by Hair Analysis in Shanghai using LC-MS-MS.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Amphetamines; Central Nervous System Stimulants; China; Chromatography, Liquid; Cocaine; Female; Hair; Hair Analysis; Humans; Illicit Drugs; Male; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Retrospective Studies; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry | 2020 |
Development of a point-of-care test for the detection of MDMA in latent fingerprints using surface plasmon resonance and lateral flow technology.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Gas Chromatography-Mass Spectrometry; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Point-of-Care Testing; Substance Abuse Detection; Surface Plasmon Resonance; Technology | 2022 |
Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Carrier Proteins; Dopamine; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin | 2022 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |
Identification and classification of ATS in oral fluid based on Ag nanoassemblies on Si surface doped with Au nanobipyramids.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Central Nervous System Stimulants; Methamphetamine; Nitrogen Compounds; Reproducibility of Results | 2023 |
Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids.
Topics: 3,4-Methylenedioxyamphetamine; Amylose; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Stereoisomerism; Tandem Mass Spectrometry | 2024 |